Empyrean Technology (301269) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
29 Apr, 2026Executive summary
Achieved record revenue of ¥1.32 billion in 2025, up 8.40% year-over-year, driven by EDA software and technical services.
Net profit attributable to shareholders was ¥60.98 million, down 44.30% year-over-year, mainly due to increased R&D and personnel expenses.
Launched 11 new EDA core tools and 9 key solutions, with significant advances in AI+EDA, 3DIC, and ecosystem development.
Maintained industry leadership in domestic EDA market, serving over 700 clients and expanding international presence.
Financial highlights
Revenue: ¥1,324,976,566.63 (+8.40% YoY); Net profit: ¥60,983,525.27 (-44.30% YoY).
Gross margin: 89.25%; Technical services revenue grew 74.93% YoY.
Operating cash flow: ¥560,653,590.02, a significant turnaround from last year.
R&D expenses: ¥859,175,124.91, accounting for 64.84% of revenue.
Basic and diluted EPS: ¥0.11 (-45% YoY); ROE: 1.19%.
Total assets: ¥6,327,842,567.91 (+12.42% YoY); Net assets: ¥5,252,047,481.67 (+4.95% YoY).
Outlook and guidance
2026 focus: dual drive of quality and innovation, further product upgrades, and AI-EDA integration.
Plans to enhance full-process EDA tool coverage, strengthen 3DIC/advanced packaging, and expand market share domestically and globally.
Continued high R&D investment and talent development to support long-term growth.
Latest events from Empyrean Technology
- Revenue up 9.65% but net loss deepened to ¥73 million amid rising costs and negative cash flow.301269
Q1 202628 Apr 2026 - Revenue up 20.98%, net profit down 45.46%, R&D at 71% of sales, new actual controller.301269
H2 202418 Dec 2025 - Revenue up, profit down sharply as costs rise; cash flow strong, subsidies key.301269
Q3 202530 Oct 2025 - Revenue up 13%, net profit down 91.9% on high R&D; new EDA tools and strong overseas growth.301269
H1 202520 Aug 2025 - Revenue up, profit down sharply as costs rise and new EDA products launch.301269
Q3 202413 Jun 2025 - Revenue up 9.6% but net profit down 54.8% as R&D investment hits 78.7% of sales.301269
H1 202413 Jun 2025 - Revenue and net profit grew strongly in Q1 2025, supported by robust cash flow and policy subsidies.301269
Q1 20256 Jun 2025